Attorneys involved in Masimo Corp. and Apple Inc.'s pulse oximetry patent infringement and trade secrets case are debating whether Apple's proposed doctor expert poses a competitive threat to Masimo's heart sensory technology and should be prevented from seeing certain confidential materials during the expert discovery phase of the case.
Supplemental documents filed by both parties Tuesday focus on the issue of whether the work of Dr. Patrick Mercier - a co-director fo...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In